As a result, several studies have proposed routine inclusion of IHC for BAP1 when investigating uveal melanoma and malignant mesothelioma (Koopmans et al., 2014, Cigognetti et al., 2015, Andrici et al., 2016). The gene discussed is BAP1; the disease is uveal melanoma.